Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation
| Autor: | Francesco B. Bianchi, Marco Lenzi, G. P. Bianchi, Fabrizio Giostra, Raffaella Francesconi, Paolo Groff, Giorgio Ballardini, Fabio Cassani, Daniela Zauli, Marco Zoli |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
Adult
Liver Cirrhosis Male Risk Pathology medicine.medical_specialty Carcinoma Hepatocellular Cirrhosis Proliferating Cell Nuclear Antigen Biopsy medicine Carcinoma Humans Aged Univariate analysis Hepatology medicine.diagnostic_test business.industry Liver Neoplasms Nuclear Proteins Middle Aged medicine.disease Liver Dysplasia Liver biopsy Hepatocellular carcinoma Immunohistochemistry Female business Cell Division |
| Zdroj: | Journal of Hepatology. 20:218-222 |
| ISSN: | 0168-8278 |
| Popis: | The immunohistochemical determination of the accessory protein of DNA-polymerase delta (PCNA), a marker of an early S-phase of the cell cycle, was used to evaluate cell proliferation retrospectively in formalin-fixed, paraffin-embedded liver biopsy sections in a group of patients with cirrhosis of similar age and duration of follow up, and with no evidence of hepatocellular carcinoma (41), including 17 patients with and 24 without hepatocellular carcinoma appearance during follow up. Proliferation was expressed as total (PCNA-TOT) and strongly (PCNA-STRO) positive nuclei per 1000 hepatocytes. The presence of dysplasia was also recorded. Histological findings and biochemical data, at the time of liver biopsy, were compared in the two groups. While total PCNA positivities were not significantly different in the two groups, strong reactivity was significantly higher in patients who eventually developed hepato-cellular carcinoma (median 0.7 vs 2.6). Univariate analysis of histological and biochemical data at the time of biopsy, followed by a stepwise regression study, showed that the significant parameters for a time-dependent disease-free state were, in decreasing order: cholesterol, PCNA-STRO, PCNA-TOT and alpha foeto-protein. Other clinical, biochemical and histological parameters, including dysplasia, provided no further information. From these data, hepatocellular proliferation can be evaluated in patients with cirrhosis with a currently available technique. Patients with high cell proliferation are at increased risk of developing hepatocellular carcinoma and may require differentiated follow up. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|